Bridging traditional knowledge and modern science: A systematic review of Ampelopsis japonica with emphasis on novel anti-cancer compounds, polypharmacology and clinical translation potential.
메타분석
1/5 보강
[ETHNOPHARMACOLOGICAL RELEVANCE] Ampelopsis japonica (Thunb.) Makino (AJ), first documented in Shen Nong Ben Cao Jing during the Eastern Han Dynasty, have been recorded for its detoxifying, heat-clear
APA
Luo W, Huang R, Tao Y (2026). Bridging traditional knowledge and modern science: A systematic review of Ampelopsis japonica with emphasis on novel anti-cancer compounds, polypharmacology and clinical translation potential.. Journal of ethnopharmacology, 356, 120835. https://doi.org/10.1016/j.jep.2025.120835
MLA
Luo W, et al.. "Bridging traditional knowledge and modern science: A systematic review of Ampelopsis japonica with emphasis on novel anti-cancer compounds, polypharmacology and clinical translation potential.." Journal of ethnopharmacology, vol. 356, 2026, pp. 120835.
PMID
41176139
Abstract
[ETHNOPHARMACOLOGICAL RELEVANCE] Ampelopsis japonica (Thunb.) Makino (AJ), first documented in Shen Nong Ben Cao Jing during the Eastern Han Dynasty, have been recorded for its detoxifying, heat-clearing and analgesic properties. The efficacy, application and related properties of AJ have been further supplemented and elaborated in classic works such as Ben Cao Gang Mu.
[AIM OF THE STUDY] This review aims to provide a critical overview of the traditional uses, phytochemistry and pharmacology, quality control and application prospects of AJ, with a focus on novel discovered compounds, polypharmacology, and mechanisms underlying its anti-cancer activity.
[MATERIALS AND METHODS] Literature was retrieved from PubMed, ScienceDirect, CNKI, and traditional Chinese medicine sources using keywords such as "Ampelopsis japonica", "pharmacological effects", and "chemical constituents". Notably, network pharmacology analysis was used to elucidate the multi-target regulatory mechanism underlying the anti-cancer effects of AJ.
[RESULTS] 137 compounds have been identified from AJ, including flavonoids, polyphenols, sterols, organic acids, triterpenes and so on. Studies demonstrate that AJ exhibits anti-cancer, anti-inflammatory, antibacterial, antioxidant, antiviral, and melanin-inhibition activities. Clinical studies validated AJ's efficacy in cancer therapy, burn healing and dermatology. Network pharmacology analysis revealed that flavonoids and polyphenols are the major anti-cancer ingredients and AKT1, EGFR, ESR1, BCL2, MMP9, PPARG, PTGS2 and SRC are the core anti-cancer targets.
[CONCLUSION] Modern pharmacological studies provided reliable evidence for traditional uses of AJ. Network pharmacology provides insights into its anti-cancer components and mechanisms. Further research should focus on molecular targets, quality standard establishment, and long-term toxicity to facilitate its clinical application, particularly in cancer therapy.
[AIM OF THE STUDY] This review aims to provide a critical overview of the traditional uses, phytochemistry and pharmacology, quality control and application prospects of AJ, with a focus on novel discovered compounds, polypharmacology, and mechanisms underlying its anti-cancer activity.
[MATERIALS AND METHODS] Literature was retrieved from PubMed, ScienceDirect, CNKI, and traditional Chinese medicine sources using keywords such as "Ampelopsis japonica", "pharmacological effects", and "chemical constituents". Notably, network pharmacology analysis was used to elucidate the multi-target regulatory mechanism underlying the anti-cancer effects of AJ.
[RESULTS] 137 compounds have been identified from AJ, including flavonoids, polyphenols, sterols, organic acids, triterpenes and so on. Studies demonstrate that AJ exhibits anti-cancer, anti-inflammatory, antibacterial, antioxidant, antiviral, and melanin-inhibition activities. Clinical studies validated AJ's efficacy in cancer therapy, burn healing and dermatology. Network pharmacology analysis revealed that flavonoids and polyphenols are the major anti-cancer ingredients and AKT1, EGFR, ESR1, BCL2, MMP9, PPARG, PTGS2 and SRC are the core anti-cancer targets.
[CONCLUSION] Modern pharmacological studies provided reliable evidence for traditional uses of AJ. Network pharmacology provides insights into its anti-cancer components and mechanisms. Further research should focus on molecular targets, quality standard establishment, and long-term toxicity to facilitate its clinical application, particularly in cancer therapy.
MeSH Terms
Animals; Humans; Antineoplastic Agents, Phytogenic; Drugs, Chinese Herbal; Ethnopharmacology; Medicine, Chinese Traditional; Neoplasms; Polypharmacology
같은 제1저자의 인용 많은 논문 (5)
- Construction of Hollow Mesoporous Selenium Loaded With Carboplatin and Clacked With Bevacizumab-Functionalized Albumin Nanoparticles for HER2+ Lung Cancer.
- Integrated Transcriptomics Reveals a SHEV ORF3-Mediated circRNA Network That Disrupts Riboflavin Metabolism and Activates the ko05212 Pathway.
- On-Chip Microfluidic Production of Sonosensitizer-Loaded Liposomes for Sonodynamic Therapy of Hepatocellular Carcinoma.
- Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study.
- Percutaneous thermal ablation-based locoregional treatment for hepatocellular carcinoma larger than 3 cm: a 10-year single-center retrospective study.